Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547729 · ClinicalTrials.gov registry record · NA
Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS)
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT00547729 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 71 participants.
The verdict
NCT00547729, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study is a feasibility study of the HeartPOD™ Heart Failure Management System with DynamicRx® (HeartPOD system) in patients with severe chronic congestive heart failure. The device being studied in this trial monitors heart function and alerts the patient and physician of necessary changes to medication. The study will assess the safety, reliability, and preliminary efficacy of the HeartPOD™ system.
Interventions
- DEVICE HeartPOD™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547729
The ClinicalTrials.gov registry entry for NCT00547729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HeartPOD™ System is the first listed.
NCT00547729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00547729 about?
NCT00547729 is a clinical study titled "Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS)". This study is a feasibility study of the HeartPOD™ Heart Failure Management System with DynamicRx® (HeartPOD system) in patients with severe chronic congestive heart failure. The device being studied in this trial monitors heart function and alerts the patient and physician of necessary changes to m...
What is the current status of trial NCT00547729?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2005-03. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00547729?
The interventions under investigation include: HeartPOD™ System (DEVICE).
Who is sponsoring clinical trial NCT00547729?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.